Aytu BioScience logo
Aytu BioScience AYTU
$ 1.58 6.04%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Aytu BioScience Balance Sheet 2011-2024 | AYTU

Annual Balance Sheet Aytu BioScience

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-8.42 M -7.01 M -3.85 M -48.5 M -45.6 M -11 M -7.01 M -802 K -8.05 M -7.35 M -2.64 M 97.6 K 67.9 K 48.3 K

Long Term Debt

10.9 M 14.7 M 14.3 M 180 K - - - - - - - - - -

Long Term Debt Current

712 K 1.26 M 1.23 M 940 K 300 K - - - - - - - - -

Total Non Current Liabilities

28.2 M 28.1 M - - 29.5 M 22.3 M 4.24 M 7.39 M 4.15 M 1.13 M 554 K - - -

Total Current Liabilities

62.2 M 69 M 64.4 M 109 M 28.3 M 5.37 M 3.39 M 3.61 M 10.1 M 1.48 M - 121 K 82.4 K -

Total Liabilities

- - 93.3 M 128 M 57.8 M 27.6 M 7.64 M 11 M 14.3 M 2.61 M 6.65 M 121 K 82.4 K 58.4 K

Deferred Revenue

- - - - 339 K - - - - 85.7 K 85.7 K - - -

Retained Earnings

-320 M -304 M -287 M -178 M -120 M -106 M -79.3 M -69.1 M -46.6 M -18.4 M -10.7 M -569 K -500 -500

Total Assets

118 M 136 M 138 M 266 M 153 M 34.7 M 21.1 M 15 M 24.3 M 18.2 M 12 M 9.67 K 12.6 K 22.8 K

Cash and Cash Equivalents

20 M 23 M 19.4 M 49.6 M 48.1 M 11 M 7.01 M 802 K 8.05 M 7.35 M 2.64 M 1.86 K 109 3.99 K

Book Value

118 M 136 M 44.3 M 138 M 95 M 7.09 M 13.4 M 4 M 10.1 M 15.6 M 5.37 M -111 K -69.7 K -35.6 K

Total Shareholders Equity

27.7 M 39.4 M 44.3 M 138 M 95 M 7.09 M 13.4 M 4 M 10.1 M 15.6 M 5.37 M -111 K -69.7 K -35.6 K

All numbers in USD currency

Quarterly Balance Sheet Aytu BioScience

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

10.4 M 10.9 M - 15 M 15 M 14.7 M 15 M 15 M 15 M 15 M 15 M 129 K 154 K 180 K 180 K 211 K 237 K - 8.16 M 23.4 M 314 K - 5.13 M 5.04 M - 5.04 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

24.8 M 28.2 M 14.4 M 34.2 M - 28.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 101 M 97.1 M 106 M 95.6 M 96.1 M 93.3 M 108 M 118 M 116 M 128 M 128 M 54 M 50.2 M 58.3 M 57.8 M 57.4 M 28.7 M 27.6 M 27.6 M 22.5 M 7.85 M 22.5 M 7.64 M 15.8 M 14.9 M 11 M 11 M 11.1 M 13 M 14.3 M 14.3 M 9.15 M 7.95 M 2.57 M 2.61 M - 6.66 M 6.65 M - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - 100 K 100 K 400 K 100 K 200 K 200 K 200 K 200 K 476 K 233 K 339 K 339 K - - - - 14 K - 14 K - - - - - - - - 85.7 K 85.7 K 85.7 K 85.7 K 85.7 K - 85.7 K 85.7 K - - - - - - - - - - - - -

Retained Earnings

-318 M -320 M -315 M -312 M -312 M -304 M -302 M -294 M -291 M -287 M -271 M -218 M -206 M -178 M -178 M -134 M -124 M -120 M -120 M -112 M -111 M -106 M -106 M -87.4 M -82.7 M -87.4 M -79.3 M -77 M -73.3 M -69.1 M -69.1 M -57.1 M -52.3 M -46.6 M -46.6 M -24 M -20.7 M -18.4 M -18.4 M -646 K -630 K -10.7 M -630 K -500 -500 -500 -500 -500 -500 -500 -500 -500 -500 -500 -500

Total Assets

116 M 118 M 129 M 131 M 133 M 136 M 147 M 141 M 150 M 138 M 169 M 224 M 228 M 266 M 266 M 167 M 141 M 153 M 153 M 74.5 M 31 M 34.7 M 34.7 M 42.4 M 18 M 42.4 M 21.1 M 18.9 M 21.2 M 15 M 15 M 21.5 M 15 M 21.5 M 20.2 M 24.4 M 21.4 M 18.2 M 18.2 M 11.2 K 5.51 K 12 M 5.51 K 7.16 K 9.67 K 9.67 K 9.67 K 11.9 K 12.6 K 12.6 K 12.6 K 18.8 K 22.8 K 22.8 K 22.8 K

Cash and Cash Equivalents

20.1 M 20 M 19.8 M 19.5 M 20 M 23 M 19.2 M 19.5 M 23.8 M 19.4 M 27.6 M 35.3 M 40.3 M 49.9 M 49.6 M 62 M 37.9 M 62 M 37.9 M 5.26 M 7.01 M 11 M 11 M 17.8 M 3.96 M 17.8 M 7.01 M 3.91 M 7.02 M 802 K 802 K 5.23 M 2.75 M 8.05 M 8.05 M 11 M 10.1 M 11 M 10.1 M 161 K 1.05 M 2.64 M 4.12 M 445 1.86 K 2.91 M 445 701 109 109 701 1.72 K 3.99 K 3.99 K 1.72 K

Book Value

- - - - 32.2 M 39.4 M 40.9 M 45.8 M 53.9 M 44.3 M 61.1 M 106 M 112 M 138 M 138 M 113 M 91.1 M 95 M 95 M 17.1 M 2.32 M 7.09 M 7.09 M 19.9 M 10.1 M 19.9 M 13.4 M 3.03 M 6.35 M 4 M 4 M 10.4 M 1.99 M 7.25 M 5.94 M 15.3 M 13.4 M 15.6 M 15.6 M 11.2 K -6.65 M 5.37 M 5.51 K 7.16 K 9.67 K 9.67 K 9.67 K 11.9 K 12.6 K 12.6 K 12.6 K 18.8 K 22.8 K 22.8 K 22.8 K

Total Shareholders Equity

29.8 M 27.7 M 30.8 M 32.9 M 32.2 M 39.4 M 40.9 M 45.8 M 48.3 M 44.3 M 57.7 M 106 M 112 M 138 M 138 M 113 M 113 M 113 M 91.1 M 17.1 M 17.1 M 17.1 M 2.32 M 19.9 M 19.9 M 19.9 M 10.1 M 3.03 M 6.35 M 3.03 M 6.35 M 10.4 M 7.19 M 10.1 M 10.1 M 15.3 M 13.4 M 15.6 M 15.6 M -44.1 K -45 K 5.37 M -45 K -126 K -111 K -111 K -111 K -82.2 K -69.7 K -69.7 K -69.7 K -47.6 K -35.6 K -35.6 K -35.6 K

All numbers in USD currency